TY - JOUR
T1 - Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future
T2 - A Nationwide Cross-Sectional Study
AU - Chowdhury, Kona
AU - Haque, Mainul
AU - Nusrat, Nadia
AU - Adnan, Nihad
AU - Islam, Salequl
AU - Lutfor, Afzalunnessa Binte
AU - Begum, Dilara
AU - Rabbany, Arif
AU - Karim, Enamul
AU - Malek, Abdul
AU - Jahan, Nasim
AU - Akter, Jesmine
AU - Ashraf, Sumala
AU - Hasan, Mohammad Nazmul
AU - Hassan, Mahmuda
AU - Akhter, Najnin
AU - Mazumder, Monika
AU - Sihan, Nazmus
AU - Naher, Nurun
AU - Akter, Shaheen
AU - Zaman, Sifat Uz
AU - Chowdhury, Tanjina
AU - Nesa, Jebun
AU - Biswas, Susmita
AU - Islam, Mohammod Didarul
AU - Hossain, Al Mamun
AU - Rahman, Habibur
AU - Biswas, Palash Kumar
AU - Shaheen, Mohammed
AU - Chowdhury, Farah
AU - Kumar, Santosh
AU - Kurdi, Amanj
AU - Mustafa, Zia Ul
AU - Schellack, Natalie
AU - Gowere, Marshall
AU - Meyer, Johanna C.
AU - Opanga, Sylvia
AU - Godman, Brian
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/1
Y1 - 2022/1
N2 - There is an increasing focus on researching children admitted to hospital with new variants of COVID-19, combined with concerns with hyperinflammatory syndromes and the overuse of antimicrobials. Paediatric guidelines have been produced in Bangladesh to improve their care. Consequently, the objective is to document the management of children with COVID-19 among 24 hospitals in Bangladesh. Key outcome measures included the percentage prescribed different antimicrobials, adherence to paediatric guidelines and mortality rates using purposely developed report forms. The majority of 146 admitted children were aged 5 years or under (62.3%) and were boys (58.9%). Reasons for admission included fever, respiratory distress and coughing; 86.3% were prescribed antibiotics, typically parenterally, on the WHO ‘Watch’ list, and empirically (98.4%). There were no differences in antibiotic use whether hospitals followed paediatric guidance or not. There was no prescribing of antimalarials and limited prescribing of antivirals (5.5% of children) and antiparasitic medicines (0.7%). The majority of children (92.5%) made a full recovery. It was encouraging to see the low hospitalisation rates and limited use of antimalarials, antivirals and antiparasitic medicines. However, the high empiric use of antibiotics, alongside limited switching to oral formulations, is a concern that can be addressed by instigating the appropriate programmes.
AB - There is an increasing focus on researching children admitted to hospital with new variants of COVID-19, combined with concerns with hyperinflammatory syndromes and the overuse of antimicrobials. Paediatric guidelines have been produced in Bangladesh to improve their care. Consequently, the objective is to document the management of children with COVID-19 among 24 hospitals in Bangladesh. Key outcome measures included the percentage prescribed different antimicrobials, adherence to paediatric guidelines and mortality rates using purposely developed report forms. The majority of 146 admitted children were aged 5 years or under (62.3%) and were boys (58.9%). Reasons for admission included fever, respiratory distress and coughing; 86.3% were prescribed antibiotics, typically parenterally, on the WHO ‘Watch’ list, and empirically (98.4%). There were no differences in antibiotic use whether hospitals followed paediatric guidance or not. There was no prescribing of antimalarials and limited prescribing of antivirals (5.5% of children) and antiparasitic medicines (0.7%). The majority of children (92.5%) made a full recovery. It was encouraging to see the low hospitalisation rates and limited use of antimalarials, antivirals and antiparasitic medicines. However, the high empiric use of antibiotics, alongside limited switching to oral formulations, is a concern that can be addressed by instigating the appropriate programmes.
KW - Antibiotics
KW - Antimicrobial stewardship programs
KW - Bangladesh
KW - COVID-19
KW - Children
KW - Guide-lines
KW - Hospitals
KW - Outcomes
UR - http://www.scopus.com/inward/record.url?scp=85123253370&partnerID=8YFLogxK
U2 - 10.3390/antibiotics11010105
DO - 10.3390/antibiotics11010105
M3 - Article
C2 - 35052982
AN - SCOPUS:85123253370
SN - 2079-6382
VL - 11
JO - Antibiotics
JF - Antibiotics
IS - 1
M1 - 105
ER -